| Literature DB >> 33193535 |
Harpreet Singh1,2, Kirandeep Kaur1, Mangaljeet Singh1, Gundeep Kaur1,3, Prabhjeet Singh1.
Abstract
Cyclophilins constitute a family of ubiquitous proteins that bind cyclosporin A (CsA), an immunosuppressant drug. Several of these proteins possess peptidyl-prolyl cis-trans isomerase (PPIase) activity that catalyzes the cis-trans isomerization of the peptide bond preceding a proline residue, essential for correct folding of the proteins. Compared to prokaryotes and other eukaryotes studied until now, the cyclophilin gene families in plants exhibit considerable expansion. With few exceptions, the role of the majority of these proteins in plants is still a matter of conjecture. However, recent studies suggest that cyclophilins are highly versatile proteins with multiple functionalities, and regulate a plethora of growth and development processes in plants, ranging from hormone signaling to the stress response. The present review discusses the implications of cyclophilins in different facets of cellular processes, particularly in the context of plants, and provides a glimpse into the molecular mechanisms by which these proteins fine-tune the diverse physiological pathways.Entities:
Keywords: FKBP; cyclophilin; hormones; immunophilins; peptidyl-prolyl cis-trans isomerase; stress
Year: 2020 PMID: 33193535 PMCID: PMC7641896 DOI: 10.3389/fpls.2020.585212
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Genome-wide analysis of cyclophilins in different organisms.
| Organism | Genes | Proteins | AAs | MW (kDa) | pI | SD | MD | Localization | References |
| 31 | 48 | 151-837 | 15.9-94.6 | 4.5-12.60 | 40 | 08 | Ch (4), Ch/P (7), Ch/ER (2), Ch/M (3), Cy (14), Cy/ER (1), CS (1), E/ER (3), N (10), V/ER (2), V/M (1) | ||
| 94 | 91 | 49-1268 | 5.7-146.1 | 4.4-11.80 | 79 | 12 | Ch (14), Cy (50), M (7), N (13), S (7) | ||
| 62 | 62 | 114-850 | 12.4-96.20 | 4.97-11.74 | 52 | 10 | Ch (13), Cy (21), M (5), N (10), SP (13) | ||
| 75 | 75 | 78-1256 | 8.50-142.5 | 4.5-11.3 | 61 | 14 | Ch (7), Ch/Cy (1), Ch/E (1),Cy (37), Cy/N (3), Cy/E (1), Cy/M (1), M (1), N (13), E (7), M/E (1), M/N (2) | ||
| 78 | 78 | 112-828 | 12.0-92.89 | 4.9-11.50 | 60 | 18 | Ch (10), Ch/E (3), Cy (36), Cy/Ch/M (1), Cy/N (1), E/Cy (2), M (3), N (10), E (6), M/Cy (1), M/N (5) | ||
| 40 | 40 | 149-795 | 15.65-89.80 | 4.9-11.50 | 32 | 08 | Ch (5), Ch/Cy (1), Cy (19), Cy/Ch/M (1), Cy/M (1), M (2), N (4), PM (1), E (4), N/M (1), PM/N/Cy (1) | ||
| 38 | 38 | 164-801 | 18.03-90.62 | 4.9-11.50 | 29 | 09 | Ch (4), Ch/E (1), Cy (16), Cy/Ch (3), E/Cy (1), E (2), E/N (1), M (1), N (4), M/N (2), N/Cyl (1), PM (1) | ||
| 33 | 33 | 125-895 | NA | NA | 21 | 12 | Cy, Ch, CS, ER, G, M, N, PM, PS | ||
| 29 | 46 | 139-1089 | 16.2-124 | 4.5-11.50 | 38 | 8 | Ch (6), Ch/P (3), Ch/ER (5), Cy (1l), Cy/M (2), Cy/ER (1), CS (2), N (8), V/ER (1), M/P (2), M (5) | ||
| 83 | 85 | 160-823 | 17.2-92.08 | 4.76-11.53 | 58 | 27 | Cy (28), Ch (22), M (09), N (19), N/ER (3), S (4) | ||
| 17 | 19 | 161-3224 | 18.0-358.22 | 5.3-10.70 | 12 | 07 | C, ER, M, N, SS | ||
| 11 | 11 | NA | NA | NA | 07 | 04 | Cy (8), E (1), M (2) | ||
| 12 | 12 | 165-663 | 16.8-74.1 | 5.01-9.46 | 08 | 04 | Cy (8), M (1), N (3) | ||
| 10 | 11 | 162-627 | 17.4-70.20 | 5.8-9.50 | 06 | 04 | Cy (6), ER (1), M (1), N (2) | ||
| 20 | 20 | 166-630 | 18.3-69.80 | NA | 15 | 05 | M (3), S (3) | ||
| 21 | 21 | 163-633 | 18.0-70.20 | NA | 16 | 05 | M (2), S (3) | ||
| 21 | 21 | 161-630 | 17.5-69.60 | NA | 16 | 05 | M (2), S (3) | ||
| 08 | 08 | 162-393 | 17.4-45.1 | 5.1-9.10 | 06 | 02 | C (2), C/N (2), V (2), M (1), ER (1) | ||
| 09 | 09 | 155-610 | 16.8-69.0 | 5.5-9.20 | 05 | 04 | C and ER | ||
| 02 | 02 | 164-190 | 21-22 | 5.0-9.70 | 02 | 00 | C and P |
Cellular functions of cyclophilins in different organisms.
| Organism | Gene | Protein | Localization | SD/MD | MW (kDa) | Proposed Functions | References |
| AtCYP18-3/ROC1 | Cytosol | SD | 18.40 | Plant pathogen interaction, brassinosteroid signaling | |||
| AtCYP19-1/ROC3 | Cytosol | SD | 18.50 | Seed development, plant-pathogen interaction | |||
| AtCYP19-2/ROC6/AtCYP2 | Cytosol | SD | 18.50 | Differentiation or development of foliar organs | |||
| AtCYP5/CYP5 | Secretory protein | SD | 19.00 | Regulation of embryogenesis | |||
| AtCYP20-1/ROC7 | Secretory protein | SD | 19.60 | Regulation of PP2A activity | |||
| AtCYP20-2 | Thylakoid luminal protein | SD | 20.00 | Biogenesis of NDH complexes | |||
| AtCYP20-3/ROC4 | Chloroplast stromal protein | SD | 19.80 | Modulates retrograde signaling, folding and assembly of SAT-1 enzyme, links redox and light signals to cysteine biosynthesis | |||
| AtCYP38/CYP38 | Thylakoid luminal protein | MD | 38.30 | Assembly and maintenance of PS-II | |||
| AtCYP57 | Cytosol | MD | 57.10 | Plant defense | |||
| AtCYP59 | Cytosol | MD | 58.80 | Regulates pre-mRNA processing | |||
| AtCYP65 | Cytosol | MD | 63.50 | Molecular chaperone and prevents protein aggregation | |||
| AtCYP71/CYP71 | Cytosol | MD | 70.70 | Regulates gene expression and organogenesis | |||
| AtCYP95 | Nucleus | MD | 94.60 | Pre-mRNA splicing | |||
| CsCYP | Nucleus | SD | 18.00 | Interacting partner for RNA polymerase-II, key player in transcriptional cycle. | |||
| LeCYP1 | Cytosol | SD | 17.90 | Auxin signaling | |||
| MsCYP20-3B | Chloroplast | SD | 20 | Regulate axillary shoot development | |||
| OsCYP2 | Cytosol and nucleus | SD | 18.30 | Regulation of initiation of lateral roots | |||
| PgCYP | Cytosol | SD | 18.70 | Antifungal activity | |||
| RcCYP1 | Cytosol | SD | 29.00 | Refolding of non-autonomous proteins | |||
| TLP40 | Thylakoid-lumen | MD | 40.00 | Regulation of activity of PS-II specific protein phosphatase | |||
| TaCYP20-2 | Thylakoid lumen | SD | 25.80 | Regulates flowering | |||
| CYPA | Cytosol | SD | 18.00 | Regulation of infectivity of HIV virions, cancer cell proliferation, chaperone | |||
| CYPB | ER | SD | 22.00 | Regulation of Hepatitis C virus replication, activation of IRF3 | |||
| CYPC | Cytoplasm/ER | SD | 22.70 | Activation of macrophages | |||
| CYPD | Mitochondria | MD | 40.70 | Protection from cell death, regulator of mitochondria permeability transition pore | |||
| hCYP33 | Nucleus | MD | 33.40 | mRNA processing, transcription regulation | |||
| Cell membrane | MD | 165.60 | NK tumor recognition complex molecule | ||||
| CPR1 | Cytosol and nucleus | SD | 17.00 | CsA receptor, regulation of meiosis | |||
| CPR2 | ER | SD | 20.50 | Enhances cell survival in response to heat shock | |||
| CPR3 | Mitochondria | SD | 20.00 | Lactate metabolism, protein folding | |||
| CPR6 | Cytosol | SD | 45.00 | Hsp90 binding, interaction with Ura2 (critical protein for pyrimidine biosynthesis) | |||
| CPR7 | Cytosol | MD | 45.00 | Hsp90 interaction, heat shock response regulator, | |||
| PPIA | Periplasm | SD | 18.13 | Folding of secreted proteins | |||
| PPIB | Cytosol | SD | 18.18 | Unknown |
Chromosomal distribution of cyclophilin genes in plants.
| Organism | Chromosome | Cyclophilin Genes | No. of Tandem/Segmental Duplicated Gene Pairs | References |
| Chr1 | 05 | NA | ||
| Chr2 | 07 | |||
| Chr3 | 09 | |||
| Chr4 | 06 | |||
| Chr5 | 04 | |||
| A01 | 11 | NA | ||
| A02 | 03 | |||
| A03 | 03 | |||
| A04 | 03 | |||
| A05 | 05 | |||
| A06 | 03 | |||
| A07 | 01 | |||
| A08 | 05 | |||
| A09 | 06 | |||
| A10 | 02 | |||
| C01 | 05 | |||
| C02 | 03 | |||
| C03 | 08 | |||
| C04 | 10 | |||
| C05 | 04 | |||
| C06 | 01 | |||
| C07 | 03 | |||
| C08 | 07 | |||
| C09 | 03 | |||
| Ch1 | 04 | 16 (tandem) | ||
| Ch2 | 03 | |||
| Ch3 | 04 | |||
| Ch4 | 03 | |||
| Ch5 | 02 | |||
| Ch6 | 04 | |||
| Ch7 | 02 | |||
| Ch8 | 00 | |||
| Ch9 | 03 | |||
| Ch10 | 03 | |||
| Ch11 | 06 | |||
| Ch12 | 04 | |||
| Ch13 | 03 | |||
| Ch14 | 01 | |||
| Ch15 | 04 | |||
| Ch16 | 00 | |||
| Ch17 | 04 | |||
| Ch18 | 03 | |||
| Ch19 | 06 | |||
| Ch20 | 03 | |||
| A01 | NA | 02 (tandem) 39 (segmental) | ||
| A02 | NA | |||
| A03 | NA | |||
| A04 | NA | |||
| A05 | NA | |||
| A06 | NA | |||
| A07 | NA | |||
| A08 | NA | |||
| A09 | NA | |||
| A10 | NA | |||
| A11 | NA | |||
| A12 | NA | |||
| A13 | NA | |||
| D01 | NA | |||
| D0 | NA | |||
| D03 | NA | |||
| D04 | NA | |||
| D05 | NA | |||
| D06 | NA | |||
| D07 | NA | |||
| D08 | NA | |||
| D09 | NA | |||
| D10 | NA | |||
| D11 | NA | |||
| D12 | NA | |||
| D13 | NA | |||
| AD1-D01 | 04 | 03 (tandem) | ||
| AD1-D02 | 03 | |||
| AD1-D03 | 02 | |||
| AD1-D04 | 03 | |||
| AD1-D05 | 01 | |||
| AD1-D06 | 02 | |||
| AD1-D07 | 04 | |||
| AD1-D08 | 05 | |||
| AD1-D09 | 02 | |||
| AD1-D10 | 03 | |||
| AD1-D11 | 02 | |||
| AD1-D12 | 03 | |||
| AD1-D13 | 02 | |||
| A2-chr1 | 05 | 02 (tandem) | ||
| A2-chr2 | 02 | |||
| A2-chr3 | 05 | |||
| A2-chr4 | 02 | |||
| A2-chr5 | 03 | |||
| A2-chr6 | 04 | |||
| A2-chr7 | 06 | |||
| A2-chr8 | 01 | |||
| A2-chr9 | 02 | |||
| A2-chr10 | 01 | |||
| A2-chr11 | 02 | |||
| A2-chr12 | 04 | |||
| A2-chr13 | 03 | |||
| D5-chr1 | 03 | 01 (tandem) | ||
| D5-chr2 | 02 | |||
| D5-chr3 | 01 | |||
| D5-chr4 | 01 | |||
| D5-chr5 | 02 | |||
| D5-chr6 | 03 | |||
| D5-chr7 | 03 | |||
| D5-chr8 | 06 | |||
| D5-chr9 | 03 | |||
| D5-chr10 | 03 | |||
| D5-chr11 | 02 | |||
| D5-chr12 | 03 | |||
| D5-chr13 | 01 | |||
| Chr1 | 05 | 07 (segmental) | ||
| Chr2 | 03 | |||
| Chr3 | 05 | |||
| Chr4 | 04 | |||
| Chr5 | 04 | |||
| Chr6 | 02 | |||
| Chr7 | 05 | |||
| Chr8 | 05 | |||
| Ch1 | 03 | NA | ||
| Ch2 | 04 | |||
| Ch3 | 03 | |||
| Ch4 | 00 | |||
| Ch5 | 01 | |||
| Ch6 | 06 | |||
| Ch7 | 03 | |||
| Ch8 | 04 | |||
| Ch9 | 02 | |||
| Ch10 | 02 | |||
| Ch11 | 01 | |||
| Ch12 | 00 | |||
| Chr1A | 01 | 06 (tandem) 15 (segmental) | ||
| Chr2A | 02 | |||
| Chr3A | 04 | |||
| Chr4A | 05 | |||
| Chr5A | 03 | |||
| Chr6A | 06 | |||
| Chr7A | 09 | |||
| Chr1B | 01 | |||
| Chr2B | 03 | |||
| Chr3B | 05 | |||
| Chr4B | 04 | |||
| Chr5B | 02 | |||
| Chr6B | 06 | |||
| Chr7B | 08 | |||
| Chr1D | 01 | |||
| Chr2D | 03 | |||
| Chr3D | 05 | |||
| Chr4D | 04 | |||
| Chr5D | 02 | |||
| Chr6D | 04 | |||
| Chr7D | 09 |
Variability in architecture of cyclophilin genes.
| Organism | Gene | Number of Exons | Size Range of Introns | No. of Introns in | Cyclophilin genes lacking introns | References | ||
| 62 | 1-14 | 39 bp ( | 0-13 | 0-1 | 0-5 | |||
| 75 | 1-21 | – | 0-20 | – | – | |||
| 78 | 1-14 | – | 0-13 | – | – | |||
| 40 | 1-15 | – | 0-14 | – | – | |||
| 38 | 1-14 | – | 0-13 | – | – | |||
| 33 | 1-14 | – | 0-13 | – | – | |||
| 83 | 1-14 | 78 bp ( | 0-13 | 0-1 | 0-1 | |||
| 10 | 1-6 | – | 0-5 | – | – | |||
| 20 | 1-8 | – | 0-7 | – | – | |||
| 21 | 1-7 | – | 0-6 | – | – | |||
| 21 | 1-6 | – | 0-5 | – | – | |||
Comparative analysis of functional domains (other than cyclophilin-like domain) in the different multi-domain cyclophilins.
| Domain | Role | References | ||||||||
| TPR | Protein-Protein interactions, Assembly of multi-protein complexes | AtCYP40/CYP40 | BnCYP40-1 | GmCYP8 | GaCYP40-1 | MtCYP40A | OsCYP40-1a | TaCYP41-1-7D | hCYP-40/Cyp40 | |
| BnCYP40-2 | GmCYP9 | GaCYP40-2 | MtCYP40B | OsCYP40-1b | TaCYP41-2-7A | |||||
| GmCYP16 | GaCYP40-3 | OsCYP40-2 | TaCYP41-3-7B | |||||||
| GmCYP17 | GaCYP41 | TaCYP44-1-6A | ||||||||
| GaCYP45 | TaCYP44-3-6B | |||||||||
| GrCYP40-1 | TaCYP44-3-6D | |||||||||
| GrCYP40-3 | ||||||||||
| GrCYP42-1 | ||||||||||
| GrCYP42-2 | ||||||||||
| GrCYP43 | ||||||||||
| GhCYP28-4 | ||||||||||
| GhCYP30-2 | ||||||||||
| GhCYP40-1 | ||||||||||
| GhCYP40-2 | ||||||||||
| GhCYP40-3 | ||||||||||
| GhCYP41 | ||||||||||
| GhCYP44-2 | ||||||||||
| GhCYP45-1 | ||||||||||
| GhCYP45-2 | ||||||||||
| GhCYP46 | ||||||||||
| GbCYP37-2 | ||||||||||
| GbCYP39-4 | ||||||||||
| GbCYP40-3 | ||||||||||
| GbCYP41-2 | ||||||||||
| GbCYP43-1 | ||||||||||
| GbCYP43-2 | ||||||||||
| GbCYP49-1 | ||||||||||
| TPR+ Zf-SCNM1+ SCNM1- acidic | Protein-Protein interaction, Protein-RNA interaction, RNA splicing | – | – | – | GbCYP66-2 | – | – | – | – | |
| WD40 repeat | Assembly of multi-protein complexes | AtCYP71 | BnCYP70-1 | GmCYP20 | GaCYP70, | MtCYP71 | OsCYP71a | TaCYP72-1-7D | hCYP-73/Cyp73 | |
| BnCYP70-2 | GmCYP35 | GbCYP58 | OsCYP71b | TaCYP72-2-7A | ||||||
| TaCYP72-3-7B | ||||||||||
| GrCYP63 | ||||||||||
| GhCYP70-1 | ||||||||||
| GhCYP70-2 | ||||||||||
| U-box | Ubiquitination | AtCYP65 | – | GmCYP18 | GaCYP65 | MtCYP65 | TaCYP64-4-4A | – | ||
| GmCYP19 | GrCYP65 | TaCYP64-5-4B | ||||||||
| GhCYP65-1 | TaCYP64-6-4D | |||||||||
| GhCYP65-2 | ||||||||||
| U-box+Zf | Ubiquitination | – | BnCYP65-1 | – | – | – | – | – | hCYP-58/Cyp60/Cyc4 | |
| BnCYP65-2 | hCYP-58i/Cyp60/Cyc4 | |||||||||
| PsbQ-like | Plant specific oxygen evolving enhancer protein 3 | – | BnCYP47-2 | – | – | – | – | – | – | |
| BnCYP47-3 | ||||||||||
| RRM | Regulation of transcription | – | – | – | – | MtCYPE-like | OsCYP59-1 | TaCYP53-1-4B | hCYP-33/Cyp33/CYPE | |
| OsCYP59-2 | TaCYP54-1-4A | |||||||||
| TaCYP55-1-4D | hCYP-57 | |||||||||
| RRM + Zf | RNA splicing | AtCYP59 | – | GmCYP56 | GrCYP72-1 | – | – | TaCYP37-1-3D | – | |
| GmCYP59 | GhCYP70-3 | TaCYP38-1-3B | ||||||||
| GhCYP70-4 | TaCYP45-1-3A | |||||||||
| GbCYP47-1 | TaCYP64-1-7A | |||||||||
| GbCYP79 | TaCYP64-2-7B | |||||||||
| TaCYP64-3-7D | ||||||||||
| Helical bundle | Signal transduction | AtCYP38/CYP38 | – | – | – | – | – | – | – | |
| TPR+ RanBD1 + ZfRanBP + E3 SUMO Ligase | RanBD1/ZfRanBP: GTPase Ran binding | – | – | – | – | – | – | – | hCYP-358/Cyp358/RanBP2 | |
| E3 SUMO Liagse: SUMO1 specific E3 ligase activity | ||||||||||
| RRM+Zf+ R/K/E-rich + ATPase | – | BnCYP112 | – | – | – | – | – | – | ||
| RRM+Zf+ Rho motif | – | – | – | – | – | MtCYP59A | – | – | – | |
| MtCYP59B | ||||||||||
| Transmembrane + Fip1 motif | – | BnCYP146 | – | – | – | – | – | – | ||
| Coiled coil + S/K-R/E rich | – | – | BnCYP52 | – | – | – | – | – | ||
| BnCYP55 | ||||||||||
| Coiled coil | – | – | – | – | GaCYP47 | – | – | – | – | |
| GrCYP47 | ||||||||||
| GhCYP47 | ||||||||||
| GhCYP48 | ||||||||||
| GbCYP40-2 | ||||||||||
| GbCYP61 | ||||||||||
| F-box | – | – | – | – | – | – | – | TaCYP23-2-6B | – | |
| TaCYP26-1-6B | ||||||||||
| TaCYP26-6-6A | ||||||||||
| PAN_4 domain | – | – | – | – | – | Medtr7g 081200 | – | TaCYP34-1-5A | – | |
| Medtr5g 013540 | TaCYP34-2-U | |||||||||
| TaCYP35-1-4B | ||||||||||
| Transposase_ Associated + Transposase Family tnp2 | – | – | – | – | – | – | OsCYP 124 | – | – | |
| AAA +AAAlid3 | Adenosine Tri Phosphatase (ATPase) | AtCYP67-1a | – | – | – | – | – | – | – | |
| AtCYP67-1b | ||||||||||
| AtCYP67-1c | ||||||||||
| POP1 + POPLD + TR | – | – | – | – | GbCYP142 | – | – | – | – | |
| Herpes_ ICP4_C | – | – | – | – | – | MtCYP95A | – | – | – | |
| MtCYP95B | ||||||||||
| Borrelia_P83 | – | – | – | – | – | MtCYP57 | – | – | – |
FIGURE 1Comparative analysis of domain architecture of Arabidopsis cyclophilins with their orthologs in human and Saccharomyces cerevisiae. The amino acid residues that define the protein domains are designated according to Galat (2004), Wang and Heitman (2005), Kumari et al. (2015), and Schiene-Fischer (2015). For Arabidopsis cyclophilins that may have alternatively spliced forms, the domain architecture is shown for only a single variant. CLD, cyclophilin-like domain; RRM, RNA recognition motif; TPR, tetratricopeptide repeat; U-box, U box domain; WD40, WD40 repeat; RanBDl, Ran binding protein 1 domain; zf RanBP, Zn-finger, Ran-binding; SR, Serine arginine rich domain. The nomenclature and alternative protein names are given in the box. Scale bar represents the length of amino acid sequence.
Biochemical characteristics of different cyclophilins.
| Source | Cyclophilin | PPIase Activity | Chaperonic activity | References | |
| Catalytic efficiency (kcat/km;M–1s–1) | Inhibition constant (Ki) for CsA (nM) | ||||
| AtCYP19-3/ROC2a,1 | 4.88x106 | 18.75 | NA | ||
| AtCYP19-4/CYP5a,1 | 5.7x106 | 8.0 | NA | ||
| AtCYP20-3/ROC4b,1 | 8.32x106 | CsA inhibitable | NA | ||
| AtCYP38/CYP38 | PPIase inactive | – | – | ||
| BnCYP18-4a,1 | 9.02 x106 | 14.2 | NA | ||
| BnCYP18-5a,1 | 5.30x106 | 22.4 | NA | ||
| BnCYP19-1a,1 | 9.07x106 | 16.6 | NA | ||
| CsCYPa,1 | 5.6x106 | NA | NA | ||
| OsCYP2a,1 | 4.5x106 | NA | NA | ||
| RcCYP1a,1 | 9.48x106 | NA | NA | ||
| TLP40a,1 | 1.6x106 | CsA insensitive | NA | ||
| TLP20 a,1 | NA | CsA inhibitable | NA | ||
| TaCYPA-1a,1 | 2.32x105 | 78.3 | NA | ||
| pCYPBa,1 | NA | 3.9 | NA | ||
| Cytosolic PPIa,1 | 1.1x107 | 6.0 | NA | ||
| Microsomal PPIa,1 | 25x106 | 6.0 | NA | ||
| Bovine | CYPa,1(Bovine cyclophilin) | 1.3 x107 | 45 ± 3 | NA | |
| ERPPIa,1 | 3.0 x106 | 5.0 | NA | ||
| Moca-CYPa,1 | 5.6x104 | 450.0 | NA | ||
| CYPAa,1 | 1.4x107 | 19 | NA | ||
| hCYPB/hCYP-22a,1 | 6.3x106 | 6.9 | NA | ||
| hCYPD/CYP-40a,1 | 1.9x106 | 300.0 | Observed | ||
| CYP18a,1 | 5.6x10–6 | 1.5 | Observed | ||
| NK-CYPa,1 | 7.4x105 | 770.0 | Observed | ||
| Matrin CYPa,1 | 1.0x106 | 220.0 | NA | ||
| PPIasea,1 | 0.9x106 | 3.6 | NA | ||
| CYPGb,1 | 1.8x105 | 8.3 | NA | ||
| XlCYP | 1.1x107 | NA | NA | ||
| PfCYP19Aa,1 PfCYP19Ba,1 | 6.3x106 5.7x106 | 10 15 | Observed Observed | ||
| PfCYPa,1 | 2.3x106 | 10.0 | NA | ||
| CYPBa,1 | PPIase active | 3.0 | NA | ||
| CYPA | PPIase active | NA | NA | ||
| CYP1 | PPIase active | NA | NA | ||
| NcCYP41a,1 | 6.5x105 | 7.0-8.0 | NA | ||
| NcCYP-19a,1 | 2.8x106 | NA | NA | ||
| yCYPA/CPR1a,1 | 1.52x107 | 40.0 ± 8 | NA | ||
| yCYPB/CPR2a,1 | 5.77x106 | 101.0 ± 14 | NA | ||
| CPR3a,1 | 5.8x106 | CsA inhibitable | NA | ||
| CPR6a,1 | 4.8x105 | CsA inhibitable | Observed | ||
| CPR7a,1 | 7.5x104 | CsA inhibitable | Observed | ||
| SpCYP3a,1 | 1.5x106 | NA | NA | ||
| PPiBa,1 | 1.1 x106 | 120.0 | NA | ||
| PPIAb,1 | 5.71x107 | 25000-50000 | NA | ||
| PPIBb,1 | 6.74x107 | 25000-50000 | NA | ||
| LpCYP18 | 4.6x106 | NA | NA | ||
| SanCYP18a,1 | 7.92 x106 | 21000 | NA | ||
| ScCYPAa,1 | 3.73x106 | 25.0 | NA | ||
| ScCYPBa,1 | 7.5x106 | 75.0 | NA | ||
| CYP1a,1 | 7.0x104 | NA | NA | ||
| CYP2a,1 | 6.1x105 | NA | NA | ||
| CYP3a,1 | 3.6x105 | NA | NA | ||
| CYP4a,1 | 1.8x104 | NA | NA | ||
| CYP5a,1 | 7.4x104 | NA | NA | ||
| CYP6a,1 | 8.4x106 | NA | NA | ||
| CYP8a,1 | 1.95x104 | NA | NA | ||
| CYP9a,1 | 1.5x104 | NA | NA | ||
| CYP10a,1 | 1.9x104 | NA | NA | ||
| CYP11a,1 | 1.5x104 | NA | NA | ||
| BmCYP1a,1 | 7.9 x106 | 860.0 | NA | ||
| BmCYP2a,1 | 1.23x107 | 9.3 | NA | ||
| CYPEa,1 | PPIase active | NA | NA | ||
| LmCYP19a,1 | 1.5x106 | 5.2 | NA | ||
| SmCYPBa,1 | 8.2x105 | 20.0 | NA | ||
| SmCYPAa,1 | 3.65x105 | 72.0 | NA | ||
| CYP18.5a,1 | NA | 32.0 | NA | ||
| CYP20a,1 | NA | 5.0 | NA | ||
| TcCYP19a,1 | NA | 18.4 | NA | ||
FIGURE 2Role of cyclophilins in regulation of Auxin-responsive genes. At low levels of Auxin, Aux/IAA proteins bind to auxin response factors (ARFs) directly or through recruitment of transcriptional corepressor such as TOPLESS (TPL) and inhibit their activity (1). When present at high levels, the auxin binds to its receptor TRANSPORT INHIBITOR RESPONSE1 (TIR1) and enhances its interaction with the highly conserved ‘degron’ motif GWPPV in domain II of Aux/IAAs (2 and 3). The Aux/IAA proteins bind to SCFTIR1-Auxin complex only when W104-P105 isomer in the ‘degron’ motif GWPPV (residues 103, 104, 105, 106 and 107, respectively, in rice) is in cis conformation. The trans conformer of W-P (T105-T106) in the ‘degron’ motif is catalyzed to cis form (c105-T106) by OsCYP2 (4). The Aux/IAA-SCFTIR1 complex leads to ubiquitination of Aux/IAA proteins (5), which are then degraded by 26S Proteasome (6), leading to expression of Auxin responsive genes including Aux/IAA (7) (Adapted from Tan et al., 2007; Mockaitis and Estelle, 2008; Jing et al., 2015; Created with BioRender.com).
Abiotic stress modulated cyclophilin genes.
| Organism | Cyclophilin gene | Accession no. | Activity | Role in Stress | References |
| PPIase activity | Cold and salt | ||||
| ND | Heat | ||||
| – | Salt | ||||
| PPIase activity | High irradiance | ||||
| PPIase inactive | High light | ||||
| ND | Cold, heat, dehydration, mannitol, salinity, light | ||||
| PPIase activity | Salt, drought | ||||
| ND | Salicylic acid, MeJA, ethylene and pathogen | ||||
| PPIase activity | Abscisic acid, sorbitol | ||||
| ND | PbN03 and salt | ||||
| ND | Salt stress, biotic stress | ||||
| – | Induced by low nitrogen | ||||
| PPIase activity | Salinity, high temperature, osmotic stress and oxidative stress | ||||
| PPIase activity | Drought | ||||
| PPIase activity | Cold stress | ||||
| PPIase activity | Osmotic stress | ||||
| PPIase inactive | Salt | ||||
| PPIase inactive | Salt, heat, cold and drought | ||||
| ND | Low temperature, abscisic acid and drought | ||||
| ND | Heat, MeJA and abscisic acid | ||||
| ND | Salt | ||||
| PPIase activity | Heat stress | ||||
| ND | Heat stress | ||||
| ND | Heat stress | ||||
| PPIase activity | Heat | ||||
| ND | Abiotic stress | ||||
| PPIase activity | Oxidative stress | ||||
| – | Biocides, CuSO4 and NaOCl | ||||
| PPIase activity | NaHCO3, NaCl, and sorbitol stress | ||||
| – | Low carbon dioxide | ||||
| Chaperonic activity | Heat stress | ||||
| ND | Salt and heat tolerance | ||||
| ND | Salt stress and irradiance stress | ||||
| – | Copper chloride and polychlorinated biphenyl | ||||
| PPIase activity | Salt, cold, heat, cadmium chloride, cobalt chloride and hydrogen peroxide | ||||
| – | Heat | ||||
| – | Cadmium, copper, hydrogen peroxide, heat, SDS and oxidative stress |